Gastrinoma before Zollinger and Ellison

Area of Science:

• Gastroenterology
• Endocrinology
• Oncology

Background:

• The Zollinger-Ellison syndrome, characterized by gastric hypersecretion and ulcers, was first described in 1955.
• A hypothesis proposed a pancreatic endocrine origin for the syndrome's manifestations.

Observation:

• A literature review identified gastrinoma cases predating the syndrome's formal definition.
• The Zollinger and Ellison publication referenced 6 prior gastrinoma cases.
• Additional cases were found in the paper's discussion and prior literature.

Findings:

• The review identified 4 to 6 additional gastrinoma cases between 1908 and 1952.
• Despite prior cases, Zollinger and Ellison were pivotal in defining the syndrome.
• They elucidated the link between islet cell tumors, gastrin, and severe gastric hypersecretion.

Implications:

• The Zollinger-Ellison contribution was a defining moment in gastrointestinal endocrinology.
• Understanding gastrinoma pathogenesis is crucial for managing related gastrointestinal disorders.
• This historical analysis highlights the evolution of diagnosing and understanding neuroendocrine tumors.